Found 100 matching trials
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype PHASE3 The purpose of this study is to evaluate if a 12-week total regimen of tela...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment PHASE3 The purpose of this study is to determine the safety, efficacy and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver Transplantation PHASE3 The purpose of this study is to evaluate the effectiveness of telaprevir in...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults PHASE1 The purpose of this study is to evaluate the effect that telaprevir has on ...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy N/A The hypothesis was to check whether baseline anti-E1E2 antibodies were corr...
Show More Location
Hôpital de la Croix Rousse
Learn More & Join Trial
Interaction Between Paroxetine and Telaprevir PHASE2 Hepatitis C (HCV) infected patients are often in need for an antidepressant...
Show More Location
Academic Medical Centre Amsterdam
Learn More & Join Trial
VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state. PHASE1 The primary objectives are to determine the effect of steady-state DRV/rtv ...
Show More Location
Multiple Locations
Learn More & Join Trial
DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) PHASE4 To examine the safety and efficacy of response guided triple therapy (PEG-I...
Show More Location
St Vincent's Hospital
Learn More & Join Trial
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients PHASE2 To assess efficacy of telaprevir, pegylated interferon alfa-2a (Peg-IFN-alf...
Show More Learn More & Join Trial
VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C PHASE2 The purpose of this study is to evaluate the efficacy and safety of two all...
Show More Location
Multiple Locations
Learn More & Join Trial